Crossmark

Engineered bone marrow mesenchymal stem cell-derived exosomes loaded with miR302 through the cardiomyocyte specific peptide can reduce myocardial ischemia and reperfusion (I/R) injury

Crossref DOI link: https://doi.org/10.1186/s12967-024-04981-7

Published Online: 2024-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gu, Jianjun

You, Jia

Liang, Hao

Zhan, Jiacai

Gu, Xiang

Zhu, Ye
Funding

Funding for this research was provided by:

National Natural Science Foundation for Young Scholars of China (81800250)

China Postdoctoral Science Foundation (2022M711417)

Tianjin Municipal Transportation Commission Science and Technology Development Plan Project (SSF2023000133)
License Information

Text and Data Mining valid from 2024-02-17

Version of Record valid from 2024-02-17
More Information

Article History

Received: 28 October 2023

Accepted: 12 February 2024

First Online: 17 February 2024

Declarations

:

: The animal procedures were approved by the Animal Ethics Committee of Yangzhou University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below